Skip to main content

The Globe and Mail

One active investor’s recipe for beating the market

Jason Del Vicario


Portfolio manager

Story continues below advertisement

The portfolio

Five stocks only: Constellation Software Inc., Ceapro Inc., BioSyent Inc., Data Communications Management Corp. and Lingo Media Corp.

The investor

Jason Del Vicario began investing at the age of 15 after his uncle gave him the book The Wealthy Barber, by David Chilton. He later started a number of investment clubs in university, read every investing book that could be found and designed a software program for screening stocks.

Now 40 years old, Mr. Del Vicario eats, breathes and sleeps stocks. "I've been in love with stock picking so much that I've become a portfolio manager and manage funds for a living," he says.

How he invests

"I run my own money differently from my clients in that my personal holdings are quite concentrated," he says. He also uses leverage, which means he borrows money on margin to buy shares.

Story continues below advertisement

This is an aggressive portfolio that aims to beat the market big. But it could also lose big. Mr. Del Vicario accepts this risk because he has the time and background to do in-depth analysis, plus the risk tolerance to go with it. Moreover, he is young enough to recover from setbacks.

A key stock-selection criterion is return on equity (ROE). "I'm looking for companies that have produced greater than 20-per-cent ROE for at least three years running." he declares.

ROE is often calculated as the ratio of net earnings to shareholders' equity (company assets minus liabilities). Mr. Del Vicario uses another variant of ROE: the ratio of cash flow to shareholder's equity.

A high ROE indicates that management is good at allocating capital or has gained a durable competitive advantage. It also indicates that a lot of capital is being generated for reinvesting in the company or paying dividends.

Management at Constellation Software "is one of the best allocators of capital in Canada," he believes. They are a software firm that is growing through acquisitions of industry-specific software businesses.

BioSyent is a small pharmaceutical company. It is growing by acquiring and licensing pharmaceutical products for sale.

Story continues below advertisement

Data Communications Management provides business-communications solutions. This bargain-priced turnaround story is restructuring operations and paying down debt.

Best move

It was "incorporating leverage" into his investment process. It has helped boost his returns.

Worst move

"I rode a Chinese firm down to zero and lost $30,000, which at the time was around 10 per cent of my portfolio. That hurt."


"Don't be afraid to take calculated risks when you are convinced the risk/reward relationship is favourable."

Want to be in Me and My Money? Contact Larry MacDonald at or his website

Report an error Licensing Options

The Globe invites you to share your views. Please stay on topic and be respectful to everyone. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

We’ve made some technical updates to our commenting software. If you are experiencing any issues posting comments, simply log out and log back in.

Discussion loading… ✨

Combined Shape Created with Sketch.

Combined Shape Created with Sketch.

Thank you!

You are now subscribed to the newsletter at

You can unsubscribe from this newsletter or Globe promotions at any time by clicking the link at the bottom of the newsletter, or by emailing us at